Cargando…

Gold nanotheranostics: future emblem of cancer nanomedicine

Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Navyatha, Bankuru, Nara, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561130/
https://www.ncbi.nlm.nih.gov/pubmed/34737836
http://dx.doi.org/10.1177/18495435211053945
_version_ 1784593065291284480
author Navyatha, Bankuru
Nara, Seema
author_facet Navyatha, Bankuru
Nara, Seema
author_sort Navyatha, Bankuru
collection PubMed
description Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal therapy (PTT) and photodynamic therapy (PDT) ability, effective contrast enhancing ability in Magnetic Resonance imaging (MRI) and Computed Tomography (CT) scan. Despite rapid breakthroughs in gold nanostructures based theranostics of cancer, the translation of gold nanostructures from bench side to human applications is still questionable. The major obstacles that have been facing by nanotheranostics are specific targeting, poor resolution and photoinstability during PTT etc. In this regard, various encouraging studies have been carried out recently to overcome few of these obstacles. Use of gold nanocomposites also overcomes the limitations of gold nanostructure probes and emerged as good nanotheranostic probe. Hence, the present article discusses the advances in gold nanostructures based cancer theranostics and mainly emphasizes on the importance of gold nanocomposites which have been designed to decipher the past questions and limitations of in vivo gold nanotheranostics.
format Online
Article
Text
id pubmed-8561130
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-85611302021-11-03 Gold nanotheranostics: future emblem of cancer nanomedicine Navyatha, Bankuru Nara, Seema Nanobiomedicine (Rij) Short Communication Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal therapy (PTT) and photodynamic therapy (PDT) ability, effective contrast enhancing ability in Magnetic Resonance imaging (MRI) and Computed Tomography (CT) scan. Despite rapid breakthroughs in gold nanostructures based theranostics of cancer, the translation of gold nanostructures from bench side to human applications is still questionable. The major obstacles that have been facing by nanotheranostics are specific targeting, poor resolution and photoinstability during PTT etc. In this regard, various encouraging studies have been carried out recently to overcome few of these obstacles. Use of gold nanocomposites also overcomes the limitations of gold nanostructure probes and emerged as good nanotheranostic probe. Hence, the present article discusses the advances in gold nanostructures based cancer theranostics and mainly emphasizes on the importance of gold nanocomposites which have been designed to decipher the past questions and limitations of in vivo gold nanotheranostics. SAGE Publications 2021-10-26 /pmc/articles/PMC8561130/ /pubmed/34737836 http://dx.doi.org/10.1177/18495435211053945 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Short Communication
Navyatha, Bankuru
Nara, Seema
Gold nanotheranostics: future emblem of cancer nanomedicine
title Gold nanotheranostics: future emblem of cancer nanomedicine
title_full Gold nanotheranostics: future emblem of cancer nanomedicine
title_fullStr Gold nanotheranostics: future emblem of cancer nanomedicine
title_full_unstemmed Gold nanotheranostics: future emblem of cancer nanomedicine
title_short Gold nanotheranostics: future emblem of cancer nanomedicine
title_sort gold nanotheranostics: future emblem of cancer nanomedicine
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561130/
https://www.ncbi.nlm.nih.gov/pubmed/34737836
http://dx.doi.org/10.1177/18495435211053945
work_keys_str_mv AT navyathabankuru goldnanotheranosticsfutureemblemofcancernanomedicine
AT naraseema goldnanotheranosticsfutureemblemofcancernanomedicine